血府逐瘀汤联合艾司奥美拉唑镁肠溶片对胃食管反流病气滞血瘀证的疗效观察

目的观察血府逐瘀汤联合艾司奥美拉唑镁肠溶片治疗胃食管反流病（GERD）气滞血瘀证的效果。 方法选取GERD气滞血瘀证患者62例,随机分为对照组（32例）和治疗组（30例）。对照组患者单纯给予艾司奥美拉唑镁肠溶片,治疗组患者给予血府逐瘀汤联合艾司奥美拉唑镁肠溶片,疗程均为8周。使用反流性疾病问卷（RDQ）积分分别评估治疗前后GERD食管症状的严重程度;使用气滞血瘀证量表积分分别评估治疗前后气滞血瘀证的严重程度。采用Fisher确切概率法检验两组患者食管症状和气滞血瘀证的治疗有效率。 结果两组患者治疗前RDQ积分和气滞血瘀证量表积分差异均无统计学意义（P＞0.05）。食管症状的改善方面,治疗组的有效率为86.2%,对照组的有效率为58.1%,治疗组优于对照组（P＜0.05）;气滞血瘀证的改善方面,治疗组的有效率为93.1%,对照组的有效率为67.7%,治疗组优于对照组（P＜0.05）。 结论与艾司奥美拉唑镁肠溶片单用相比,血府逐瘀汤联合艾司奥美拉唑镁肠溶片对GERD气滞血瘀证具有更好的治疗作用。     

Taiwan Blood Donation Program: A Model for Development

In 1974, the Taiwan National Blood Program had not yet been fully developed. The volunteer donor base was less than 5% and there was no organized national structure or regulation of blood services. Following the founding of the Blood Donation Association and the Blood Services Foundation, promotion of an all-volunteer blood program, increased utilization of blood components and the standardization of laboratory methods were strategies that led to the development of the Taiwan National Blood Program. In 1991, 1,066,082 units of blood were collected in Taiwan, serving a population of about 20 million. There are currently 6 major blood centers and 13 blood stations. Blood donation is now 100% volunteer and 78% of all blood collected is separated into 10 available components. With national organization and regulation, the transition has taken 17 years and has resulted in a community-based, all-volunteer blood supply.     

慢性肾衰竭患者C-反应蛋白与营养不良及感染的关系

目的　探讨慢性肾衰竭患者C 反应蛋白 (CRP)与营养不良及感染的关系。方法　将5 1例受检的慢性肾衰竭患者分为感染组和非感染组 ,检测其CRP、白蛋白 (Alb)、前白蛋白 (PA )和血肌酐 (Scr)及胆固醇 (TCH)水平。结果　感染组CRP水平明显高于非感染组 (P <0 .0 1) ,感染组血浆白蛋白、前白蛋白及血浆白蛋白 /血肌酐 (Alb/Scr)比值明显低于非感染组 (P <0 .0 1) ,两组间血肌酐和胆固醇比较差异无显著性 (P >0 .0 5 )。慢性肾衰竭患者CRP水平与血浆白蛋白、前白蛋白水平及血浆白蛋白 /血肌酐比值呈负相关 (P <0 .0 1) ,CRP水平与血肌酐及胆固醇的相关性不显著 (P >0 .0 5 )。结论　慢性肾衰竭患者CRP水平可反映机体营养状况及炎症反应     

Plateletpheresis Experience with the Haemonetics Blood Processor 30, the IBM Blood Processor 2997, and the Fenwal CS-3000 Blood Processor1,2

Comparisons were made of the apheresis instruments Haemonetics Blood Processor 30, IBM Blood Processor 2997 and Fenwal CS-3000, for collection of platelets from normal donors. With each instrument the mean recovery was at least 4times10¹¹ platelets per procedure, and each instrument afforded a safe and reliable collection. The Haemonetics Blood Processor gave the lowest recovery of platelets per minute per procedure. The IBM Blood Processor 2997 required the longest time for set-up and priming and processed 1.5 liters more donor blood per collection than the other instruments. The Fenwal CS-3000, which is a computer-controlled instrument, was the least time consuming. The donor suffered a significantly greater drop in platelet count after collection with the IBM Blood Processor 2997 (31%) than after collection with the other instruments (19%), and we were unable to account for this observation.     

From blood transfusion to patient blood management: a new paradigm for patient care and cost assessment of blood transfusion practice

The ageing population in developed countries, including Australia, is putting increasing demands on blood transfusion services. With a falling donor pool there is likely to be a shortage of blood and blood products in the next 20 to 30 years unless there are significant changes in medical practice. The National Health and Medical Research Council/Australasian Society of Blood Transfusion Clinical Practice Guidelines on the Use of Blood Components from 2001 are being redeveloped by the National Health and Medical Research Council/Australian and New Zealand Society of Blood Transfusion as evidence-based patient-focused Patient Blood Management guidelines with the aim of improving patient outcomes by reducing inappropriate blood and blood product use and targeting therapies for improving the management of anaemia and coagulopathies.     

Inactivation of a European strain of West Nile virus in single- donor platelet concentrate using the INTERCEPT blood system

BACKGROUND AND OBJECTIVE: In order to prevent West Nile virus (WNV) contaminations by transfusion, the French National Blood Service decided to evaluate the INTERCEPT Blood System's efficiency on a European strain. MATERIALS AND METHODS: Culture supernatant of WNV was used to infect six platelets concentrates. Viral titre was determined by plaque reduction neutralization test before and after viral inactivation using the INTERCEPT Blood System. RESULTS: In all assays, the absence of plaque forming unit was observed after viral inactivation. The log reduction observed ranged between > 5.1 logs to > 5.2 logs. CONCLUSION: INTERCEPT Blood System is a commercially viral inactivation method potentially useful in order to prevent WNV transmission by blood products in France during re-emerging outbreaks.     

Book Reviews

Book Reviewed in this article:
Blood Transfusion in Clinical Medicine , 8th edn. By P. L. Mollison, C. P. Engelfriet and Marcela Contreras.
Developmental Control of Globin Gene Expression . Edited by G. Stamatoyannopoulos and A. W. Nienhuis. Progress in Clinical and Biological Research.
Blood, Blood Products and AIDS . Edited by R. Madhok, C. D. Forbes and B. Evatt.     

Heterosexually acquired HIV infection in female blood donors: Case series between 1985-1990

The case histories aimed to describe the risk behaviours of a series of seven Australian women who acquired the human immunodeficiency virus (HIV) through heterosexual contact. Between 1985 and 1990 eight HIV antibody positive female donors were identified through routine HIV antibody screening at the NSW Red Cross Blood Transfusion Service. These donors were recalled and interviewed to assess risk factors for HIV and establish how and/or why the declaration form and the interview process prior to donation did not identify a risk factor. The most likely risk factor in seven cases was then assessed by the Blood Bank to be heterosexual transmission. Histories for three cases were based on the standard risk assessment interview at the Blood Bank and four case histories were based on additional interviews conducted independently from the Blood Bank with informed consent.     

Book Reviews

Book reviewed in this article:
E.L. Snyder, M. S. Kennedy (eds.) Blood Transfusion Therapy: A Physicians Hand-book
Edward L. Snyder Blood Transfusion Therapy: A Self-Assessment Examination     

Rheological influences on thrombosis.

Blood flow plays important roles in the localization and morphology of thrombosis within the circulation. Blood flow properties (rheological variables) are associated with thrombotic risk factors and thrombotic risk; conversely their modification may reduce thrombotic risk.     

Book Reviews

Diagnosis and Treatment of Haemophilia , 2nd edn. By H. S. STRAUSS.
Blood Groups of Animals .
Polymorphismes Biochimiques des Animaux .
Storage of Blood . By B. A. L. HURN.     

Book Reviews

Proceedings of the Sixth Congress of the International Society of Blood Tranfusion in Conjunction with the Ninth Annual Meeting of the American Association of Blood Banks.
Hemophilia a d Hemophilioid Diseases. International Symposium. Ed. K. M. B rinkhous .     

两种方法检测胃液潜血的比较

目的:探讨胶体金法和邻甲苯胺法检测空腹患者胃液潜血的差异.方法:收集58例大于24 h未进饮食(为肠外营养)、3 d内未吃肉类食品、未服用Vc、铁剂等影响邻甲苯胺法检测药物的胃插管患者的胃液标本,用胶体金法和邻甲苯胺法同时检测潜血.结果:胶体金法有31例阳性,阳性率为53.4%,邻甲苯胺法有44例阳性,阳性率为75.9%,两者有显著性差异(P<0.005).结论:邻甲苯胺法检测空腹患者胃液潜血优于胶体金法.     

Books Received

An Introduction to Blood Group Serology . By K ATHLEEN E. B OORMAN and B ARBARA E. D ODD .
Disorders of the Blood. 8th edition. By S IR L IONEL E. H. W HITBY and C. J. C. B RITTON .
Human Blood Coagulation and its Disorders. 2nd edition. By R OSEMARY B IGGS and R. G. M ACFARLANE .
Ionizing Radiations and Cell Metabolism. Ciba Foundation Symposium. Ed. G. E. W. W OLSTENHOLME and C ECILIA M. O'C ONNOR .     

研发计算机软件系统在临床输血工作管理中的应用

<正>临床输血管理是连接医院、患者、血站的纽带和桥梁,建立先进的计算机软件系统管理临床输血全过程和输血科日常工作式已成为输血科现代化管理的需要。一套系统、完善、规范、准确的临床输血全过程和输血科日常工作管理系统,将为临床输血管理提供安全、可靠的保证。网络平台不仅加快了实验数据的传送速度,为抢救患者争取了时间,同时也明确了各部门的责任,为     

Changes in the prevalence distribution of hypertension: Connecticut adults 1978-79 to 1982

In the Spring and Summer of 1982 the Second Connecticut Blood Pressure Survey (CBPS-II) was completed. This survey is independent of, but essentially identical in design and implementation to the First Connecticut Blood Pressure Survey reported on by Freeman et al. [1]. This paper compares the results of the two surveys using the same analytic techniques as reported previously [2]. In addition, a model for analyzing the components of hypertension control is utilized in the analysis. Finally, the implications of the survey comparison are discussed in the context of the Connecticut High Blood Pressure Program (CHBP) [3].     

Are blood pressure levels taken during a secondary care diabetic clinic likely to be higher than when measured in primary care?

Blood pressure management guidelines are widely available. Our aim was to examine differences in blood pressure on the same subjects in primary and secondary care. We identified 661 diabetic subjects with measurements with the aid of the SAIL databank. Blood pressure in primary care was significantly lower than secondary care.     

Book review

Leukocyte - Depleted Blood Products Editors: T.A. Lane, G. Myllyla. (Part of Current Studies in Hematology and Blood Transfusion. Editors: J. Leikola, P. Lundsgaard- Hansen). Karger, Basel, 1994. 143 pages. Price DM206, US $137.75.     

Blood Distribution Systems and the Exchange of Information between Hospital Blood Banks and Regional Blood Centers

Abstract. The advantages and disadvantages of centralized or decentralized reactive or predictive blood distribution systems are presented. A decentralized, predictive distribution system, being used by the Long Island Blood Services Division of the Greater New York Blood Program is described and its applicability to most regional blood supply organizations is emphasized.     

The Japan Marrow Donor Program, the Japan Cord Blood Bank Network and the Asia Blood and Marrow Transplant Registry

The annual number of hematopoietic stem cell transplants in Japan is about 3500, which are performed by more than 300 medical teams throughout the country. The Japan Marrow Donor Program (JMDP), initiated in 1991, has recruited 300,000 volunteer donors, accepted 20,000 patients and has facilitated more than 8000 unrelated bone marrow transplants. The Japan Cord Blood Bank Network (JCBN), which started in 1999, has collected 20,000 cord blood units and facilitated 4000 cord blood transplants up to now. To fulfill the requirement for HSCT, international collaborations as well as domestic efforts are considered to be important for the future. The Center for International Blood and Marrow Transplant Research (CIBMTR) and European Blood and Marrow Transplant Group (EBMT) initiated a movement to create a common clinical record form last winter and called on the Asia-Pacific Blood and Marrow Transplantation Group (APBMT) to join them. Globalization of patient and donor registration for HSCT has become realistic and this could contribute to both the further improvement of patient outcomes and to further donor safety.